Advertisement

Topics

Shire’s haemophilia A drug secures EU marketing authorisation

19:00 EST 15 Jan 2018 | Pharmaceutical Technology

Shire has secured marketing authorisation from the European Commission (EC) for its Antihaemophilic Factor (Recombinant) (ADYNOVI) PEGylated drug in the...
Read More...

The post Shire’s haemophilia A drug secures EU marketing authorisation appeared first on Pharmaceutical Technology.

Original Article: Shire’s haemophilia A drug secures EU marketing authorisation

NEXT ARTICLE

More From BioPortfolio on "Shire’s haemophilia A drug secures EU marketing authorisation"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Recombinant DNA
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...